IceCure Medical (NASDAQ: ICCM) director lists no shares

Rhea-AI Filing Summary

IceCure Medical Ltd. filed an initial Form 3 for director David Salton, reporting his status as a director of the company. This filing does not list any specific equity holdings or derivative positions and shows no reported transactions at this time.

Key Figures

Buy transactions: 0 Sell transactions: 0 Holding entries: 0

3 metrics

Buy transactions 0 Number of buy transactions reported for David Salton in this Form 3

Sell transactions 0 Number of sell transactions reported for David Salton in this Form 3

Holding entries 0 Number of non-derivative holding entries reported for David Salton

Key Terms

Form 3, reporting person, derivative securities

3 terms

Form 3 regulatory

"filed an initial <b>Form 3</b> for director David Salton"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons" lists David Salton as the reporting person"

derivative securities financial

"No derivative positions are listed in the derivativeSummary"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

FAQ

What does the ICCM Form 3 filing for David Salton report?

The Form 3 for IceCure Medical Ltd. (ICCM) identifies David Salton as a director. It reports no specific stock or derivative holdings and no insider transactions in this initial ownership statement.

Does the ICCM Form 3 for David Salton show any insider buying or selling?

No. The Form 3 data for ICCM show 0 buy and 0 sell transactions. It is an initial ownership report and does not indicate any recent trading activity by or for David Salton.

Is David Salton a 10% owner of IceCure Medical Ltd. according to this Form 3?

According to the Form 3, David Salton is reported as a director of ICCM and is not flagged as a 10% owner. The filing does not list specific share amounts in this dataset.

Are there any derivative securities reported for David Salton in ICCM’s Form 3?

No derivative positions are listed. The derivativeSummary is empty, indicating no options or similar derivative securities are reported for David Salton in this Form 3 snapshot.

What trading plan information is disclosed for David Salton in ICCM’s Form 3?

The Form 3 data show no indication of a Rule 10b5-1 trading plan for David Salton. The 10b5-1 plan field is null, and there are no related transaction footnotes in this dataset.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 08/17/2026 - 08:18 AM Accepted by SEC EDGAR 08/17/2026 - 08:17 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Salton David

(Last) (First) (Middle)

7 HA'ESHEL ST., PO BOX 3163

(Street)

CAESAREA 3079504

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/12/2026

3. Issuer Name and Ticker or Trading Symbol
IceCure Medical Ltd. [ ICCM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ David Salton	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)